Search results
Results from the WOW.Com Content Network
The treatment objective is to cure the disease and prevent the progression of the acute to chronic form of the disease. All cases of suspected schistosomiasis should be treated regardless of presentation because the adult parasite can live in the host for years.
Leaky gut syndrome; Legg–Calvé–Perthes disease; Legius syndrome; Leiner's disease; Lelis syndrome; Lemierre's syndrome; Lennox–Gastaut syndrome; Lenz microphthalmia syndrome; Lenz–Majewski syndrome; Leriche's syndrome; Leschke syndrome; Lesch–Nyhan syndrome; Lethal congenital contracture syndrome; Lethal white syndrome
Historical accounts of Katayama disease dates back to the discovery of S. Japonicum in Japan in 1904. The disease was named after an area it was endemic to, Katayama district, Hiroshima, Japan. [11] If left untreated, it will develop into a chronic condition characterized by hepatosplenic disease and impaired physical and cognitive development.
Amplified musculoskeletal pain syndrome (AMPS) is an illness characterized by notable pain intensity without an identifiable physical cause. [ 1 ] [ 6 ] Characteristic symptoms include skin sensitivity to light touch, also known as allodynia .
It is the only drug authorised by the EMA to treat the whole disease in adults, and by the FDA to treat patients who have cataplexy with the indication to be used for combating excessive daytime sleepiness. [4] [20] This drug helps to normalise sleep architecture and inhibits the intrusion REM sleep elements like paralysis during the day. [4]
Meds can be used to manage aspects of the disease. [3] Treatment depends largely on the progression of the individual disease and the nature of the symptoms presented. Antimalarial medications, corticosteroids and other medications may be prescribed, as the treating physician considers appropriate: [19] Nonsteroidal anti-inflammatory drugs for ...
Hirayama disease, also known as monomelic amyotrophy (MMA), [1] [2] is a rare motor neuron disease first described in 1959 in Japan. Its symptoms usually appear about two years after adolescent growth spurt and is significantly more common in males, with an average age of onset between 15 and 25 years.
Catalepsy is a symptom of certain nervous disorders or conditions such as Parkinson's disease and epilepsy. It is also a characteristic symptom of cocaine withdrawal, as well as one of the features of catatonia. It can be caused by schizophrenia treatment with anti-psychotics, [3] such as haloperidol, [4] and by the anesthetic ketamine. [5]